HDAC2通过LncRNA-H19调节角质形成细胞EMT/MET参与创面再上皮化的分子机制研究

基本信息
批准号:81871568
项目类别:面上项目
资助金额:57.00
负责人:徐祥
学科分类:
依托单位:中国人民解放军第三军医大学
批准年份:2018
结题年份:2022
起止时间:2019-01-01 - 2022-12-31
项目状态: 已结题
项目参与者:龙皎月,邢伟,郭韡,李战,胡雪停,邱伟,赵榕森,姚孟维
关键词:
去乙酰化酶2创面愈合上皮间质转化再上皮化长链非编码H19
结项摘要

Keratinocyte (KC) EMT plays an important role in wound re-epithelialization, a key process of normal wound healing, however hyperproliferative and nonmigratory Keratinocyte shows in the Margin area of chronic wounds, which impairs wound re-epitheliazation, but its molecular mechanism remains largely unclear. Our preliminary studies demonstrated that HDAC2-knockout KC cells showed increased migration and EMT features, such as decreased E-cadherin and increased Zeb1. It was found that LncRNA-H19, a positive regulator of EMT, was significantly upregulated in HDAC2-knockout KC cells. On the other hand, the special and temporal expression of HDAC2 during wound healing was proved to be regulated by TGF-β, a factor known to be involved in wound healing, re-epithelialization, and EMT. So, we speculated that, HDAC2 may negatively regulate EMT of KCs by downregulating H19, and together with TGF-β, mediate spatial and temporal regulation of EMT/MET of KCs to promote wound re-epithelialization and wound healing. To confirm this hypothesis, this study intends to investigate how the TGF-β-HDAC2-H19 signaling axis regulate EMT of KCs to mediate wound re-epithelialization, which shall expand our understanding of wound epithelization and inspire new treatment strategy.

KC细胞介导创面再上皮化是创面正常愈合的关键环节,而难愈创面创缘KC细胞常呈现过度增殖,但移行和上皮化障碍,目前机制不清。前期预实验证实,HDAC2敲除的KC细胞迁移增加,呈现EMT表型,EMT标记分子E-钙粘蛋白表达下降,Zeb1表达上调,同时EMT正性调控分子H19表达显著上调。另外,HDAC2于创面愈合过程中呈时空性表达,并受TGF-β(创面愈合、上皮化及EMT的重要调控分子)所调控。为此,我们提出"HDAC2通过直接阻遏H19的表达,负性调控KC细胞EMT,并协同TGF-β信号时空性介导KC细胞的EMT/MET进程,有效调控创面再上皮化和愈合"的机制假设。为证实此假设,本研究拟应用HDAC2敲除及GFP标记的KC细胞,从细胞和动物层面通过系列生物学实验,探索TGF-β-HDAC2-H19信号轴对KC细胞EMT/MET和创面再上皮化的作用机制,为发展难愈创面的治疗新策略提供理论依据。

项目摘要

KC细胞介导创面再上皮化是创面正常愈合的关键环节,明晰其分子调控机制对于难愈创面治疗有重要的理论指导意义。在本项目研究中,我们发现创面微环境中的TGF-β可以通过TGF-β/smad信号通路正向调控KC细胞HDAC2的表达,并促进上皮间质转化(EMT)的发生。进一步地,我们发现敲除/敲低HDAC2可以促进细胞EMT的发生。通过全转录组测序筛选及验证,我们发现LncRNA H19是HDAC2调控EMT发生的下游靶基因。在机制研究中我们发现,HDAC2通过结合转录因子SP1并催化组蛋白H3K27的去乙酰化修饰抑制LncRNA H19的表达,而H19则通过吸附MiR-22-3P并上调MMP14的表达促进EMT的发生。此外,在本项目的资助下,我们还发现:①长链非编码RNA LncDC对于KC细胞的分化有促进作用;②细胞程序性死亡-配体1(PD-L1)通过调控巨噬细胞的极化促进创面愈合。我们的研究揭示了TGF-β/HDAC2/H19信号轴对上皮间质转化的调控作用及机制,并发现Lnc-DC及PD-L1分别对于KC细胞功能和创面愈合的重要调控作用,为发展难愈创面的治疗新策略提供理论依据。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
2

农超对接模式中利益分配问题研究

农超对接模式中利益分配问题研究

DOI:10.16517/j.cnki.cn12-1034/f.2015.03.030
发表时间:2015
3

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

DOI:10.1016/j.intimp.2021.107374
发表时间:2021
4

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

DOI:10.1080/15476286.2017.1377868.
发表时间:2017
5

低轨卫星通信信道分配策略

低轨卫星通信信道分配策略

DOI:10.12068/j.issn.1005-3026.2019.06.009
发表时间:2019

徐祥的其他基金

相似国自然基金

1

白介素27通过调控角质形成细胞增殖参与银屑病发病的机制研究

批准号:81872536
批准年份:2018
负责人:杨斌
学科分类:H1202
资助金额:57.00
项目类别:面上项目
2

NLRC4炎症小体通过促进角质形成细胞活化参与银屑病免疫紊乱的机制研究

批准号:81703119
批准年份:2017
负责人:曹天宇
学科分类:H1202
资助金额:20.00
项目类别:青年科学基金项目
3

创面修复中表皮角质形成细胞增殖调控模式的差异性研究

批准号:30570705
批准年份:2005
负责人:陆树良
学科分类:H1703
资助金额:24.00
项目类别:面上项目
4

CTGF通过Wnt途径调节黑色素瘤细胞上皮细胞间质转化(EMT)

批准号:31471236
批准年份:2014
负责人:李永君
学科分类:C0602
资助金额:80.00
项目类别:面上项目